Rabeprazole Oral Tablet, Gastro-Resistant 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Rabeprazole: Oral tablet, gastro-resistant (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_5931.JPG
Aciphex 20mg DR Tablet
Eisai Inc
Pill Identification: ACIPHEX 20 
Drug Image file DrugItem_18405.JPG
Rabeprazole 20mg DR Tablet
Kremers Urban Inc. a Division of UCB, Inc.
Pill Identification: KU  |  7
Drug Image file DrugItem_17197.JPG
Rabeprazole 20mg DR Tablet
Teva Pharmaceuticals USA Inc
Pill Identification: 93 64 
Drug Image file DrugItem_17198.JPG
Rabeprazole 20mg DR Tablet
Mylan Pharmaceuticals Inc
Pill Identification: M R7 
Drug Image file DrugItem_18000.JPG
Rabeprazole 20mg DR Tablet
AvKARE, Inc.
Pill Identification: 93 64 
Drug Image file DrugItem_18406.JPG
Rabeprazole 20mg DR Tablet
AvKARE, Inc.
Pill Identification: KU  |  7

What is this Medicine?

RABEPRAZOLE (ra BE pray zole) prevents the production of acid in the stomach. It is used to treat gastroesophageal reflux disease (GERD), certain ulcers, inflammation of the esophagus, and Zollinger-Ellison Syndrome.

In-Depth Information
Select a Medication

Rabeprazole Sodium 20mg Delayed-Release Tablet

NDC: 136680107
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Esophagitis, Zollinger-Ellison Syndrome, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)

Sometimes used for but not FDA approved for the following conditions:
Helicobacter Pylori (H. Pylori) Eradication, Dyspepsia, Gastric Ulcer, Eosinophilic Esophagitis, Pyrosis (heartburn)

Storage Information
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Rabeprazole Sodium 20mg Delayed-Release Tablet

Reported Side Effects for Rabeprazole Sodium 20mg Delayed-Release Tablet

Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<3.6%*
Severity: MILD
Onset: EARLY
Liver Infection Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
<9.9%*
Severity: MILD
Onset: EARLY
Hepatic Encephalopathy Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-4.5%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
1.8-4.5%*
Severity: MILD
Onset: EARLY
Infection Incidence:
2.0%*
Severity: MILD
Onset: DELAYED
Constipation Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
3.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Rabeprazole

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.